CO6811858A2 - Nuevos derivados de imidazol útiles para el tratamiento de artritis - Google Patents
Nuevos derivados de imidazol útiles para el tratamiento de artritisInfo
- Publication number
- CO6811858A2 CO6811858A2 CO13275568A CO13275568A CO6811858A2 CO 6811858 A2 CO6811858 A2 CO 6811858A2 CO 13275568 A CO13275568 A CO 13275568A CO 13275568 A CO13275568 A CO 13275568A CO 6811858 A2 CO6811858 A2 CO 6811858A2
- Authority
- CO
- Colombia
- Prior art keywords
- arthritis
- treatment
- imidazole derivatives
- derivatives useful
- new imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161490222P | 2011-05-26 | 2011-05-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6811858A2 true CO6811858A2 (es) | 2013-12-16 |
Family
ID=46148987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13275568A CO6811858A2 (es) | 2011-05-26 | 2013-11-22 | Nuevos derivados de imidazol útiles para el tratamiento de artritis |
Country Status (22)
Country | Link |
---|---|
US (1) | US8648200B2 (es) |
EP (1) | EP2714679A1 (es) |
JP (1) | JP2014518886A (es) |
KR (1) | KR20130143138A (es) |
CN (1) | CN103562200A (es) |
AR (1) | AR086254A1 (es) |
AU (1) | AU2012259234A1 (es) |
BR (1) | BR112013029692A2 (es) |
CA (1) | CA2836240A1 (es) |
CO (1) | CO6811858A2 (es) |
CR (1) | CR20130534A (es) |
DO (1) | DOP2013000276A (es) |
EA (1) | EA201391568A1 (es) |
EC (1) | ECSP13013047A (es) |
IL (1) | IL229318A0 (es) |
MA (1) | MA35128B1 (es) |
MX (1) | MX2013013859A (es) |
SG (1) | SG195020A1 (es) |
TN (1) | TN2013000434A1 (es) |
TW (1) | TW201311658A (es) |
WO (1) | WO2012161965A1 (es) |
ZA (1) | ZA201308609B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8871947B2 (en) | 2013-02-04 | 2014-10-28 | KingChem LLC | Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester |
CN103467379A (zh) * | 2013-08-23 | 2013-12-25 | 江苏恒安化工有限公司 | 3-三氟甲基-1-甲基吡唑-4-甲酸的制备方法 |
CN103483250B (zh) * | 2013-10-08 | 2015-07-22 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
CN103601675B (zh) * | 2013-10-08 | 2015-10-28 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
US9139507B2 (en) | 2013-12-09 | 2015-09-22 | KingChem LLC. | Process for the preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate and its analogs |
TWI651310B (zh) * | 2014-02-20 | 2019-02-21 | 日商日本煙草產業股份有限公司 | 三化合物及其醫藥用途 |
JP6566444B2 (ja) | 2014-03-19 | 2019-08-28 | カーザ グローバル エルエルシーCurza Global, Llc | 2−(アシルアミノ)イミダゾールを含む組成物および方法 |
KR20160134865A (ko) | 2014-04-14 | 2016-11-23 | 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 | 아미드 유도체 및 이의 약제학적으로 허용되는 염, 이의 제조방법 및 이의 의학적 적용 |
US20170057943A1 (en) * | 2015-08-17 | 2017-03-02 | Japan Tobacco Inc. | Hydroxytriazine compounds and pharmaceutical use thereof |
WO2018184019A1 (en) | 2017-03-31 | 2018-10-04 | Curza Global, Llc | Compositions and methods comprising substituted 2-aminoimidazoles |
CN109293567A (zh) * | 2018-11-23 | 2019-02-01 | 上海睿腾医药科技有限公司 | 一种5-溴-2-甲基烟酸乙酯的合成方法 |
CN114007691A (zh) | 2019-06-14 | 2022-02-01 | 詹森药业有限公司 | 吡啶氨基甲酸酯及其作为GluN2B受体调节剂的用途 |
EP3990476A1 (en) | 2019-06-25 | 2022-05-04 | Gilead Sciences, Inc. | Flt3l-fc fusion proteins and methods of use |
CN118178645A (zh) | 2019-10-18 | 2024-06-14 | 四十七公司 | 用于治疗骨髓增生异常综合征和急性髓系白血病的联合疗法 |
JP2022552748A (ja) | 2019-10-31 | 2022-12-19 | フォーティ セブン, インコーポレイテッド | 抗cd47及び抗cd20による血液癌の治療 |
TWI778443B (zh) | 2019-11-12 | 2022-09-21 | 美商基利科學股份有限公司 | Mcl1抑制劑 |
CN110845426A (zh) * | 2019-11-29 | 2020-02-28 | 都创(上海)医药科技有限公司 | 一种2-氯-5-氰基嘧啶化合物制备方法 |
PE20230376A1 (es) | 2019-12-24 | 2023-03-06 | Carna Biosciences Inc | Compuestos moduladores de la diacilglicerol quinasa |
US11692038B2 (en) | 2020-02-14 | 2023-07-04 | Gilead Sciences, Inc. | Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8) |
CR20220547A (es) | 2020-05-01 | 2022-12-15 | Gilead Sciences Inc | Compuestos de 2,4-dioxopirimidina inhibidores de cd73 |
TW202302145A (zh) | 2021-04-14 | 2023-01-16 | 美商基利科學股份有限公司 | CD47/SIRPα結合及NEDD8活化酶E1調節次單元之共抑制以用於治療癌症 |
WO2022245671A1 (en) | 2021-05-18 | 2022-11-24 | Gilead Sciences, Inc. | Methods of using flt3l-fc fusion proteins |
EP4359415A1 (en) | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271650A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
CA3222439A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
CN117480155A (zh) | 2021-06-23 | 2024-01-30 | 吉利德科学公司 | 二酰基甘油激酶调节化合物 |
WO2023076983A1 (en) | 2021-10-28 | 2023-05-04 | Gilead Sciences, Inc. | Pyridizin-3(2h)-one derivatives |
CA3235986A1 (en) | 2021-10-29 | 2023-05-04 | Gilead Science, Inc. | Cd73 compounds |
AU2022417491A1 (en) | 2021-12-22 | 2024-05-23 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
AU2022419982A1 (en) | 2021-12-22 | 2024-06-06 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
TW202340168A (zh) | 2022-01-28 | 2023-10-16 | 美商基利科學股份有限公司 | Parp7抑制劑 |
TW202346277A (zh) | 2022-03-17 | 2023-12-01 | 美商基利科學股份有限公司 | Ikaros鋅指家族降解劑及其用途 |
US20230355796A1 (en) | 2022-03-24 | 2023-11-09 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
TW202345901A (zh) | 2022-04-05 | 2023-12-01 | 美商基利科學股份有限公司 | 用於治療結腸直腸癌之組合療法 |
TW202400138A (zh) | 2022-04-21 | 2024-01-01 | 美商基利科學股份有限公司 | Kras g12d調節化合物 |
WO2024006929A1 (en) | 2022-07-01 | 2024-01-04 | Gilead Sciences, Inc. | Cd73 compounds |
WO2024064668A1 (en) | 2022-09-21 | 2024-03-28 | Gilead Sciences, Inc. | FOCAL IONIZING RADIATION AND CD47/SIRPα DISRUPTION ANTICANCER COMBINATION THERAPY |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7439360B2 (en) * | 2004-10-15 | 2008-10-21 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US8084466B2 (en) * | 2007-12-18 | 2011-12-27 | Janssen Pharmaceutica Nv | Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor |
US20100324086A1 (en) | 2008-02-19 | 2010-12-23 | Novasaid Ab | Compounds and methods |
UY32470A (es) | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones |
WO2010127152A2 (en) * | 2009-04-29 | 2010-11-04 | Irm Llc | Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors |
EP2491007B1 (en) | 2009-10-23 | 2013-09-25 | Boehringer Ingelheim International GmbH | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
AR084174A1 (es) * | 2010-12-21 | 2013-04-24 | Lilly Co Eli | Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica |
-
2012
- 2012-05-03 AR ARP120101556A patent/AR086254A1/es not_active Application Discontinuation
- 2012-05-04 TW TW101116086A patent/TW201311658A/zh unknown
- 2012-05-10 WO PCT/US2012/037200 patent/WO2012161965A1/en active Application Filing
- 2012-05-10 US US13/468,122 patent/US8648200B2/en not_active Expired - Fee Related
- 2012-05-10 SG SG2013085154A patent/SG195020A1/en unknown
- 2012-05-10 CN CN201280025230.2A patent/CN103562200A/zh active Pending
- 2012-05-10 BR BR112013029692A patent/BR112013029692A2/pt not_active IP Right Cessation
- 2012-05-10 JP JP2014512861A patent/JP2014518886A/ja active Pending
- 2012-05-10 CA CA2836240A patent/CA2836240A1/en not_active Abandoned
- 2012-05-10 AU AU2012259234A patent/AU2012259234A1/en not_active Abandoned
- 2012-05-10 KR KR1020137030893A patent/KR20130143138A/ko not_active Application Discontinuation
- 2012-05-10 EA EA201391568A patent/EA201391568A1/ru unknown
- 2012-05-10 EP EP12723323.7A patent/EP2714679A1/en not_active Withdrawn
- 2012-05-10 MX MX2013013859A patent/MX2013013859A/es unknown
-
2013
- 2013-10-18 CR CR20130534A patent/CR20130534A/es unknown
- 2013-10-24 TN TNP2013000434A patent/TN2013000434A1/fr unknown
- 2013-11-07 IL IL229318A patent/IL229318A0/en unknown
- 2013-11-15 MA MA36452A patent/MA35128B1/fr unknown
- 2013-11-15 ZA ZA2013/08609A patent/ZA201308609B/en unknown
- 2013-11-22 DO DO2013000276A patent/DOP2013000276A/es unknown
- 2013-11-22 CO CO13275568A patent/CO6811858A2/es not_active Application Discontinuation
- 2013-11-25 EC ECSP13013047 patent/ECSP13013047A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA201391568A1 (ru) | 2014-04-30 |
ECSP13013047A (es) | 2014-01-31 |
DOP2013000276A (es) | 2014-03-31 |
BR112013029692A2 (pt) | 2017-01-17 |
CN103562200A (zh) | 2014-02-05 |
AR086254A1 (es) | 2013-11-27 |
US8648200B2 (en) | 2014-02-11 |
CR20130534A (es) | 2014-03-12 |
US20120302608A1 (en) | 2012-11-29 |
KR20130143138A (ko) | 2013-12-30 |
MA35128B1 (fr) | 2014-05-02 |
EP2714679A1 (en) | 2014-04-09 |
IL229318A0 (en) | 2014-01-30 |
AU2012259234A1 (en) | 2013-11-14 |
CA2836240A1 (en) | 2012-11-29 |
SG195020A1 (en) | 2013-12-30 |
TW201311658A (zh) | 2013-03-16 |
TN2013000434A1 (en) | 2015-03-30 |
ZA201308609B (en) | 2015-05-27 |
MX2013013859A (es) | 2014-05-28 |
JP2014518886A (ja) | 2014-08-07 |
WO2012161965A1 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6811858A2 (es) | Nuevos derivados de imidazol útiles para el tratamiento de artritis | |
CO6821964A2 (es) | Compuestos para el tratamiento de la adicción | |
CO6940432A2 (es) | Compuestos de 1-arilcarbonilo-4-oxi-piperidina útiles para el tratamiento de enfermedades neurodegenerativas | |
CO6950482A2 (es) | Composiciones para el tratamiento de la artritis reumatoide y métodos para su utilización | |
CO7061081A2 (es) | Derivados macrocíclicos para el tratamiento de enfermedades | |
CO6960542A2 (es) | Polimorfos de inhibidores de cinasas | |
CO6920296A2 (es) | Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona | |
ES2898695T8 (es) | Derivados de benzoxaborol para el tratamiento de infecciones bacterianas | |
CO6960110A1 (es) | Composición aditiva para fluidos de tratamiento de pozos | |
SMT201600153B (it) | Derivato di azolo | |
CO7030960A2 (es) | Inhibidores de pak para el tratamiento de los trastornos de proliferación celular | |
CO6870035A2 (es) | Nuevos derivados bicíclicos de dihidroquinolina-2-ona | |
SMT201600328B (it) | Nuovi composti come inibitori di diacilglicerolo aciltransferasi | |
CO6791602A2 (es) | Métodos y sistemas para el tratamiento de pozos | |
EP2729234A4 (en) | PROCESS FOR OZONOLYSIS OF ORGANIC COMPOUNDS | |
CO6970598A2 (es) | Derivados de 4-pregenen-11ss-17-21-triol-3,20-diona para el tratamiento de afecciones oculares | |
EP2697204A4 (en) | FLUORATION OF ORGANIC COMPOUNDS | |
FR2975396B1 (fr) | Procede de preparation de 5-hydroxymethylfurfural | |
BR112013016073A2 (pt) | método para produçao de compostos orgânicos | |
EP2726418A4 (en) | PRE-TREATMENT OF MUD | |
CO6821965A2 (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
BR112014009524A2 (pt) | composto heterocíclico bicíclico | |
BR112014004742A2 (pt) | calheira | |
BR112013033306A2 (pt) | compostos orgânicos | |
BR112013032213A2 (pt) | cocho independente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |